The Gates Foundation has teamed up with Indian drugmakers to accelerate the distribution of a groundbreaking $40 HIV shot, which is expected to significantly enhance HIV prevention efforts. This partnership is crucial as it aims to make this innovative treatment accessible to millions, marking a significant step forward in the fight against HIV. With the potential to change lives, this initiative not only highlights the importance of collaboration in healthcare but also brings hope to those at risk.

The Gates Foundation is teaming up with Indian drugmakers to accelerate the distribution of a groundbreaking HIV prevention shot, which is expected to cost around $40 per patient annually. This initiative is significant as it aims to make this promising treatment accessible to millions, potentially transforming the landscape of HIV prevention and care.